TNDM Q3 2020 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$2B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$124M+30.6% YoY

Gross Profit

$65M52.8% margin

Operating Income

-$1M-0.8% margin

Net Income

-$9M-7.6% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+13.2%

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$8M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$673M

Total Liabilities

$346M

Stockholders' Equity

$327M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$124M	$95M	+30.6%
Gross Profit	$65M	$51M	+28.9%
Operating Income	-$1M	-$6M	+83.2%
Net Income	-$9M	-$3M	-224.3%